RETRACTED: Diallyl disulfide antagonizes DJ ‐1 mediated proliferation, epithelial–mesenchymal transition, and chemoresistance in gastric cancer cells
Authors:
- 20 April 2024
- journal article
- retracted article
- Published by Wiley in Environmental Toxicology
- Vol. 39 (8) , 4105-4119
Abstract
Diallyl disulfide (DADS), an organic component of allicin abstracted from garlic, possesses multi‐target antitumor activity. DJ‐1 performs a vital function in promoting AKT aberrant activation via down‐regulating phosphatase and tensin homologue (PTEN) in tumors. It is unknown the involvement of DJ‐1 in epithelial–mesenchymal transition (EMT) of gastric cancer (GC) cells. The purpose of this study is to investigate whether diallyl disulfide (DADS) intervenes in the role of DJ‐1 in GC. Based on the identification that the correlation between high DJ‐1 and low PTEN expression in GC was implicated in clinical progression, we illuminated that down‐regulation of DJ‐1 by DADS aided in an increase in PTEN expression and a decrease in phosphorylated AKT levels, which was in line with the results manifested in the DJ‐1 knockdown and overexpressed cells, concurrently inhibiting proliferation, EMT, migration, and invasion. Furthermore, the antagonistic effects of DADS on DJ‐1 were observed in in vivo experiments. Additionally, DADS mitigated the DJ‐1‐associated drug resistance. The current study revealed that DJ‐1 is one of potential targets for DADS, which hopefully provides a promising strategy for prevention and adjuvant chemotherapy of GC.Keywords
This publication has 33 references indexed in Scilit:
- CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axisDrug Resistance Updates, 2022
- Modulation of signaling pathways by DJ-1: An updated overviewRedox Biology, 2022
- Cancer drug resistance induced by EMT: novel therapeutic strategiesArchives of Toxicology, 2021
- Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathwayPhytomedicine, 2020
- DJ-1 promotes colorectal cancer progression through activating PLAGL2/Wnt/BMP4 axisCell Death & Disease, 2018
- Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?Oncogene, 2018
- Expression of DJ-1 in Neurodegenerative Disorders2017
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implicationsNature Reviews Clinical Oncology, 2017
- Diallyl disulfide inhibits growth and metastatic potential of human triple‐negative breast cancer cells through inactivation of the β‐catenin signaling pathwayMolecular Nutrition & Food Research, 2015
- DJ-1 upregulates breast cancer cell invasion by repressing KLF17 expressionBritish Journal of Cancer, 2014